-
Loading metrics
A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases
- Bertrand Nalpas,
- Philippe Ichaï,
- Laure Jamot,
- Nicolas Carbonell,
- Marika Rudler,
- Philippe Mathurin,
- François Durand,
- Guido Gerken,
- Michael Manns,
- Christian Trautwein
x
- Published: March 16, 2016
- https://doi.org/10.1371/journal.pone.0150733